Pharmacovigilance Quality Management TrainingArab – EU – US
PVA-2025Herunterladen
PVA-2025Herunterladen
SCHOLZ Pharma GmbH was founded by Dr. Bianca Scholz in 2007 and offers business consulting and services in the field of pharmaceuticals (pharmaceutical / medical / healthcare). In addition to our core competencies of audit and inspections in the areas of GCP, GLP, GMP and GVP, our team at SCHOLZ Pharma GmbH also offer customized solutions in the field of pharmaceutical management, coaching, training and document management from development to market presence. SCHOLZ Pharma GmbH works closely together as a team in order to be able to offer you a comprehensive service in the field of GxP. Our experts for the respective areas of GxP support you individually or as a team to meet your specific requirements. In addition to our core competencies, SCHOLZ Pharma GmbH works closely with experts in the following guidelines.
Dr. Bianca Scholz is pharmacist since 1996 with a PhD in the field of neonatology/gynecology. She holds a certificate as Lead Auditor following ISO 19011 and ISO 9001 as well as Quality Manager and Management Technician within the European Organization for (EOQ). Furthermore, she has a supplement qualification for drug safety information and the Management of Public pharmacies with focus on the following areas of expertise:
Dr. Bianca Scholz worked for Baxter Healthcare (2002-2008) as Quality Manager/Auditor in the Team of Corporate Compliance Services. She was Lead Auditor for Pharmacovigilance audits (GVP) and audits of clinical trials (GCP) and supported the Team as Subject Matter Expert in other GxP fields (GMP, GLP, GDP). The audits were performed worldwide. Dr. Bianca Scholz founded Scholz Consulting & Project Management in 2008 (ScholzPharma GmbH since 2015). Since than Dr. Bianca Scholz and team provide services to multiple worldwide operating companies with focus Audit Management, Inspection Readiness Projects, GAP analysis, support in Corrective/Preventive Action Management, Set-up of SOP Systems and assessment of Quality Management Systems.
In addition, Dr. Bianca Scholz provides services as Head of Quality Control (Leiter Qualitätskontrolle) in the GMP environment for small and middle size companies. Dr. Bianca Scholz prepared, supported and attended as Consultant several inspections by Competent Authorities such as FDA/US, MHRA/UK, ANSM/FR, EMA/EU, PEI-Paul Ehrlich Institut/Germany, SwissMedic/CH, BfArM-Bundesinstitut für Arzneimittel/Germany as well as several Federal German Authorities e.g. Regierungspräsidium Tübingen, Karlsruhe, Darmrstadt etc.
Associations, activities and membership:
Dr. Bianca Scholz is speaker for:
Drug safety is playing an increasingly important role in the pharmaceutical industry. Both in clinical development and later with marketed drugs, continuous monitoring and controlled documentation are expected by the responsible authorities and required by the law. SCHOLZ Pharma GmbH supports you with implementation and maintenance of your pharmacovigilance system. The services of SCHOLZ Pharma GmbH include amongst other things:
Clinical studies are determined by a variety of legal and regulatory requirements. Successful approval of clinical trials is only possible if the clinical studies are planned and carried out in these regulated environments. SCHOLZ Pharma GmbH offers you services in connection with the clinical development of pharmaceuticals in the following scope:
• Contract Research Organization audits
• Audits from testing centers
• Create and maintain the trial master file
• Training for investigators, monitors
• Document Management: Creating & Reviewing Study Documentation, Enrollment
Application / EC / CA Approval, Study Design, Study Plan, CRF, Patient Information, Study Reports
The quality management standard ISO 9001 is the most widespread and important international standard in quality management (QM). Certification to ISO 9001 is possible for entrepreneurs and organizations of all sizes and in all sectors and provides the basis for the continuous improvement process of the internal quality management system (QMS).
ISO 9001 specifies the minimum requirements for a quality management system to be implemented by companies in order to meet customer requirements and other product or service quality requirements. In the field of pharmaceuticals, these requirements include all the rules and regulations as well as guidelines, ordinances and special authority requirements that are individually determined and implemented by SCHOLZ Pharma GmbH for customers.
The availability of appropriate process descriptions (SOPs), the implementation of training systems, quality controls, and the regular performance of system audits are essential to ensuring a sufficient quality standard for each company.
SCHOLZ Pharma GmbH supports you in the ISO 9001 quality management implementation as well as in the preparation for a certification. We assist you with the daily monitoring and continuous improvement of your quality management system.
Numerous legal and regulatory requirements necessitate the execution of audits. Many companies are not prepared for this or deliberately choose to delegate these tasks to an objective service provider. Audits serve the internal control of processes and procedures and make a valuable contribution to the continuous improvement of the processes. SCHOLZ Pharma GmbH carries out audits in all areas of the pharmaceutical industry (GxP) and offers assistance in handling challenging topics and corrective measures.
For your individual inspection preparation, SCHOLZ Pharma GmbH can look back on many years of experience in the preparation and support of inspections by authorities (FDA, EMA, PEI, BfArM, EU state authorities). Thus, your team can be prepared by the SCHOLZ Pharma GmbH for the inspection targeted and with company-specific training and the review and adjustment of all relevant documents.
The EU Medical Device Regulation (MDR) – replaces the previous Medical Device Directive (93/42 / EEC), the Medical Device Directive (MDD) and the directive on active implantable medical devices – Active Implantable Medical Devices, AIMD (90 / 385 / EEC). The manufacturers of medical devices and the clinics face new challenges in order to guarantee a complete documentation of the medical devices.
The new EU regulation came into force on May 25, 2017, but the authorities have granted a three-year transition period. The new regulation will have to be implemented from May 26th, 2020. For the manufacturers of medical devices, the implementation involves for all products the assignment of a unique device identification number (UDI). In certain cases, the regulation provides for certain transition periods. These depend on the risk class of medical devices. For products of risk class III (e.g. cardiac catheter), implementation is mandatory from May 2021. Products of risk class II (e.g. single-use syringes) must be clearly coded from May 2023 at the latest. For products in risk class I (e.g. reusable surgical instruments), the deadline expires in May 2025.
Since the amendment to the Medical Devices Act (MPG) and the Ordinance on Clinical Trials of Medical Devices (MPKPV) came into force, the qualifications of persons involved in clinical studies, in particular investigators and members of a test group, must be demonstrated and evaluated by ethics committees. ScholzPharma GmbH supports you in your new obligations.
This includes:
• Implementation and monitoring of ISO 13485
• Implementation and monitoring of ISO 14155
• Quality management system for medical devices
• Planning, control, implementation and evaluation of your internal audit according
to DIN EN ISO 13485 based on ISO 19011
• Qualification audit of service providers in connection with PMS / PMCF studies
• Market observation using PMS (post-market surveillance) / PMCF (post-market
clinical follow-up)
• Compilation of performance and safety data
coming soon
In order to build and maintain the strong business and quality results we rely on the strong abilities, competencies and passion of every single member of our team. We believe to accomplish strong results of high quality in collaboration with cross functional colleagues providing holistic and superior results, packages, concepts, and processes for you as our customers. ScholzPharma GmbH will ensure to assign the resources with the needed expertise and training history according to your specific needs.
SCHOLZ Pharma GmbH unterstützt Sie mit Auditerfahrung weltweit. In der Vergangenheit haben wir unsere Auditfähigkeiten in folgenden Ländern unter Beweis gestellt:
Our customers are the best judges of how good we really are. Here are some opinions
„Ich bedanke mich noch einmal sehr herzlich bei Ihnen für das konstruktive, produktive und kollegiale Audit. Da ja aller guten Dinge Drei sind, stehen die Chancen nicht schlecht, dass wir uns bestimmt noch einmal wiedersehen, … und wenn es ein Audit ist. 😉
„Dr. Bianca Scholz has been our PV Auditor since 2016 and her role has been recently expanded to include GCP audits. She conducts internal audits as well as external audits of third Parties on our behalf. She also provided valuable assistance in design of the company risk based PV audit strategy. She brings with her a thorough knowledge of applicable PV, GCP and GxP regulations, guidelines, policies and procedures. In addition she has excellent interpersonal skills and provides pragmatic solutions to identified gaps in processes. I can highly recommend Dr. Bianca Scholz as an auditor.“
“Frau Dr. Scholz hat uns von der ersten Minute an bei der Etablierung eines Pharmakovigilanz-Systems für unsere neue Arzneimittelproduktion beraten und ist für uns als pharmazeutisches Unternehmen unersetzlich geworden! Von Beginn an hat sie uns perfekt darin beraten, was für uns als kleines Unternehmen mit wenigen Produkten notwendig ist und wie die Erfordernisse am besten umzusetzen sind. Jede Frage wird umgehend beantwortet und auch kurzfristig angefragte Schulungen oder Überarbeitungen werden stets durch Frau Dr. Scholz möglich gemacht. Wir sind sehr froh, Frau Dr. Scholz als Beraterin an unsere Seite zu haben.“
„Seit 2018 beauftragen wir Frau Dr. Scholz regelmäßig mit PV-Audits bei unseren Distributionspartnern, teilweise kombiniert mit GDP-Aspekten. Zusätzlich hat sie auch unser eigenes PV-System im Rahmen eines zweitägigen internen Systemaudits überprüft und eine Reihe sehr zielführender Vorschläge zur weiteren Optimierung gemacht. Hervorheben möchte ich ihre wichtigen Impulse zur Weiterentwicklung einer auf unser Unternehmen zugeschnittenen risikobasierten PV-Auditstrategie. Wir haben besonders ihre offene, souveräne und lösungsorientierte Herangehensweise, ihren breiten Erfahrungsschatz im GVP- und GDP-Bereich und ihre Flexibilität in Hinblick auf die aus der jeweiligen Vertragssituation erwachsenden Bedürfnisse schätzen gelernt.“
For the conduct of an internal audit at our Pharmacovigilance and Medical Scientific Affairs department, we were able to engage Dr. Bianca Scholz. As a result, we received a very comprehensive and professional assessment of our pharmacovigilance (PV) system, focusing on the interfaces between company-internal departments, international collaboration, and related contract management as well as compliance with local (GVP) and global regulations. Dr. Bianca Scholz has a high level of expertise in auditing and a profound knowledge of PV requirements and related expectations of authorities worldwide. In addition, she is open-minded, has excellent interpersonal skills and excellent communication skills. We are very grateful to her for carrying out the audit and assessment of our PV system.
“In view of an upcoming GVP related Regulatory Authority inspection, Dr. Bianca Scholz’ support has been of great value due to her profound knowledge in Pharmacovigilance regulations, guidelines, procedures and processes. She made significant contributions to understand Pharmacovigilance related expectations especially with focus interdepartmental connections and impact within our company.
Her wealth of experience in interpersonal skills guiding a learn process to find company specific solutions and process improvement was very constructive. We appreciate her open-minded advice and targeted assistance and can always recommend her as consultant and auditor.”
„Ich fand es ein sehr angenehmes und hilfreiches Audit und Ihren Ansatz sehr gut. Man fühlt sich nicht nur einfach auditiert, sondern gleichzeitig gut beraten, wie man‘s verbessern kann. Ich hoffe, wir werden irgendwann noch einmal gemeinsam Audits haben! “
Vielen Dank auch für das Audit. Ich habe viel Spaß und Freude gehabt, bei dem Tag, sofern man es sagen darf, wenn es um ein Audit geht 😉 Ich bewundere Ihre Souveränität im Umgang mit dem Kunden. Ihre jahrelange Erfahrung war absolut spürbar. Es ist ein Geschenk für uns, mit dir zu arbeiten.
PVA-2025Herunterladen
This website is using cookies to improve the user-friendliness. You agree by using the website further.